The CONFIRM score significantly improved the prediction of all-cause mortality over the NCEP ATP III score in patients undergoing CCTA (categorical NRI 0.06; 95% CI 0.02-0.10; P=0.005).
Cohort (n=15,219)
Yes
Does the CONFIRM score improve prediction of all-cause mortality compared to traditional clinical risk scores in patients undergoing CCTA?
The CONFIRM score derived from CCTA provides significantly better long-term prediction of all-cause mortality compared to traditional clinical risk scores.
Effect estimate: categorical NRI 0.06 (95% CI 0.02-0.10)
p-value: p=0.005
AIMS: To investigate the long-term performance of the CONFIRM score for prediction of all-cause mortality in a large patient cohort undergoing coronary computed tomography angiography (CCTA). METHODS AND RESULTS: Patients with a 5-year follow-up from the international multicentre CONFIRM registry were included. The primary endpoint was all-cause mortality. The predictive value of the CONFIRM score over clinical risk scores (Morise, Framingham, and NCEP ATP III score) was studied in the entire patient population as well as in subgroups. Improvement in risk prediction and patient reclassification were assessed using categorical net reclassification index (NRI) and integrated discrimination improvement (IDI). During a median follow-up period of 5.3 years, 982 (6.5%) of 15 219 patients died. The CONFIRM score outperformed the prognostic value of the studied three clinical risk scores (c-indices: CONFIRM score 0.696, NCEP ATP III score 0.675, Framingham score 0.610, Morise score 0.606; c-index for improvement CONFIRM score vs. NCEP ATP III score 0.650, P 5 years after CCTA. These findings are consistent in a large variety of patient subgroups.
Deseive et al. (Thu,) conducted a cohort in Patients undergoing coronary computed tomography angiography (CCTA) (n=15,219). CONFIRM score vs. Clinical risk scores (Morise, Framingham, and NCEP ATP III score) was evaluated on All-cause mortality (categorical NRI 0.06, 95% CI 0.02-0.10, p=0.005). The CONFIRM score significantly improved the prediction of all-cause mortality over the NCEP ATP III score in patients undergoing CCTA (categorical NRI 0.06; 95% CI 0.02-0.10; P=0.005).